Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO)

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-11-05
DOI
https://doi.org/10.1371/journal.pone.0321819
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO)

Tayfun Bişgin, Onur Bayraktar, Feza Karakayalı, Naci̇ye Çiğdem Arslan et al.
PLoS ONE
Colorectal Cancer Surgical Treatments
article

Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO)

Tayfun Bişgin, Onur Bayraktar, Feza Karakayalı, Naci̇ye Çiğdem Arslan, İlknur Erenler Kılıç, Aras Emre Canda
article en

Abstract

No abstract available for this paper.
PLoS ONEVol. 20(11)
Başkent University (TR), Dokuz Eylül University (TR), Haliç University (TR), Kent Hastanesi (TR), Istanbul Technical University (TR)
Openalex Percentile: Top 56%
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.